Showing results (1-10 of 105) with videos related to
Sort By:
Pageof 11
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|February 17, 2009
Systemic treatment by inhalation of macromolecules--principles, problems, and examplesR Siekmeier, G ScheuchJournal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|February 17, 2009
Inhaled insulin--does it become reality?R Siekmeier, G ScheuchJournal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|March 28, 2008
Novel approaches to enhance pulmonary delivery of proteins and peptidesG Scheuch, R SiekmeierJournal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|February 6, 2010
Treatment of systemic diseases by inhalation of biomolecule aerosolsR Siekmeier, G ScheuchAdvances in Experimental Medicine and Biology|September 26, 2014
Inhalation of macrolides: a novel approach to treatment of pulmonary infectionsR Siekmeier, T Hofmann, G ScheuchEuropean Journal of Medical Research|February 17, 2010
Novel devices for individualized controlled inhalation can optimize aerosol therapy in efficacy, patient care and power of clinical trialsA Fischer, J Stegemann, G Scheuch, et al.Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|March 28, 2008
Inhalation of tobramycin in patients with cystic fibrosis: comparison of two methodsR Dopfer, P Brand, B Müllinger, et al.Experimental Lung Research|January 9, 2004
Pulmonary deposition of monodisperse aerosols in patients with chronic obstructive pulmonary diseaseT Meyer, B Müllinger, K Sommerer, et al.European Journal of Medical Research|December 15, 2010
Lung deposition of inhaled alpha-1-proteinase inhibitor (alpha 1-PI) - problems and experience of alpha1-PI inhalation therapy in patients with hereditary alpha1-PI deficiency and cystic fibrosisR SiekmeierAdvances in Experimental Medicine and Biology|July 25, 2012
Market surveillance of in vitro diagnostics by the BfArM until end 2010: how safe are products for tumor diagnostics?R Siekmeier, D WetzelPageof 11